HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of JMJD2A in infiltrating duct carcinoma was markedly higher than fibroadenoma, and associated with expression of ARHI, p53 and ER in infiltrating duct carcinoma.

Abstract
Jumonji Domain Containing 2A (JMJD2A) may be a cancer-associated gene involved in human breast cancer. With a view to investigating expression of JMJD2A in human breast cancer and benign lesion tissues as well as relationship between JMJD2A and tumor related proteins, histological and immunohistochemical analysis, Western blot and quantitative real-time PCR in infiltrating duct carcinoma and fibroadenoma for JMJD2A and immunohistochemical analysis and quantitative real-time PCR in infiltrating duct carcinoma for tumor related proteins (ARHI, p53, ER, PR and CerbB-2) were performed. Histological examination validated the clinical diagnosis. The JMJD2A positive rate of infiltrating duct carcinoma was significantly higher than fibroadenoma by immunohistochemical analysis. The mean optical density of JMJD2A in infiltrating duct carcinoma was higher than fibroadenoma by western blot. JMJD2A mRNA level in infiltrating duct carcinoma was higher than fibroadenoma by quantitative real-time PCR. Spearman correlation analysis revealed that the expression of JMJD2A was associated with ARHI, p53 and ER from immunohistochemical results respectively. Pearson correlation analysis revealed that the expression of JMJD2A was associated with ARHI, p53 and ER from quantitative real-time PCR results respectively. Expression of JMJD2A in infiltrating duct carcinoma was higher, and associated with ARHI, p53 and ER. The results may take JMJD2A as a potential diagnostic and therapeutic target in human breast cancer.
AuthorsBei-Xu Li, Jia Li, Cheng-Liang Luo, Ming-Chang Zhang, Hui Li, Li-Liang Li, Hong-Fei Xu, Yi-Wen Shen, Ai-Min Xue, Zi-Qin Zhao
JournalIndian journal of experimental biology (Indian J Exp Biol) Vol. 51 Issue 3 Pg. 208-17 (Mar 2013) ISSN: 0019-5189 [Print] India
PMID23678541 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DIRAS3 protein, human
  • Receptors, Estrogen
  • Receptors, Progesterone
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Jumonji Domain-Containing Histone Demethylases
  • KDM4A protein, human
  • Receptor, ErbB-2
  • rho GTP-Binding Proteins
Topics
  • Breast Neoplasms (metabolism)
  • Carcinoma, Ductal, Breast (metabolism)
  • Cell Line, Tumor
  • Female
  • Fibroadenoma (metabolism)
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Jumonji Domain-Containing Histone Demethylases (biosynthesis)
  • Receptor, ErbB-2 (biosynthesis)
  • Receptors, Estrogen (biosynthesis)
  • Receptors, Progesterone (biosynthesis)
  • Tumor Suppressor Protein p53 (biosynthesis)
  • rho GTP-Binding Proteins (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: